New publication in Jama Network Open
The PEPITES team has just published an article in JAMA Network Open on the risk of severe COVID-19 associated with multiple sclerosis (MS) and anti-CD20 antibody treatments as part of Edouard Januel's epidemiology thesis (supervised by Caroline Papeix and Florence Tubach).
The risk of severe COVID-19 was higher in patients with progressive MS compared to those with relapsing-remitting MS. An increased risk of severe COVID-19 associated with anti-CD20 treatments was observed in patients with relapsing-remitting MS.